Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marianna Meschiari and Massimo Girardis.
Marianna Meschiari
Connection Strength
1.312
Massimo Girardis
  1. Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study. Multidiscip Respir Med. 2021 Jan 15; 16(1):737.
    View in: PubMed
    Score: 0.231
  2. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951043.
    View in: PubMed
    Score: 0.215
  3. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.060
  4. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection. Nat Commun. 2021 07 29; 12(1):4677.
    View in: PubMed
    Score: 0.060
  5. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
    View in: PubMed
    Score: 0.060
  6. Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies. Clin Infect Dis. 2021 07 01; 73(1):e252-e255.
    View in: PubMed
    Score: 0.060
  7. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest. 2021 08; 160(2):454-465.
    View in: PubMed
    Score: 0.059
  8. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.058
  9. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.058
  10. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
    View in: PubMed
    Score: 0.058
  11. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
    View in: PubMed
    Score: 0.057
  12. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
    View in: PubMed
    Score: 0.057
  13. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020 12 07; 12(12):e13001.
    View in: PubMed
    Score: 0.057
  14. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol. 2020 09; 50(9):1283-1294.
    View in: PubMed
    Score: 0.056
  15. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
    View in: PubMed
    Score: 0.056
  16. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.056
  17. Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm. Cytometry A. 2020 07; 97(7):668-673.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.